EMS-CHEMIE HOLDING Valuation
Is EMSNZ undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of EMSNZ when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: EMSNZ (CHF607) is trading above our estimate of fair value (CHF577.4)
Significantly Below Fair Value: EMSNZ is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for EMSNZ?
Key metric: As EMSNZ is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
What is EMSNZ's PE Ratio? | |
---|---|
PE Ratio | 30.8x |
Earnings | CHF 461.53m |
Market Cap | CHF 14.23b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 6.6x |
Enterprise Value/EBITDA | 25.2x |
PEG Ratio | 4.2x |
Price to Earnings Ratio vs Peers
How does EMSNZ's PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 26.3x | ||
CRDA Croda International | 28.3x | 14.9% | UK£4.6b |
JMAT Johnson Matthey | 4.1x | -24.7% | UK£2.2b |
VCT Victrex | 53x | 29.3% | UK£911.6m |
TET Treatt | 19.7x | 10.3% | UK£283.1m |
EMSNZ EMS-CHEMIE HOLDING | 30.8x | 7.4% | CHF 14.2b |
Price-To-Earnings vs Peers: EMSNZ is expensive based on its Price-To-Earnings Ratio (30.8x) compared to the peer average (26.3x).
Price to Earnings Ratio vs Industry
How does EMSNZ's PE Ratio compare vs other companies in the European Chemicals Industry?
1 Company | Price / Earnings | Estimated Growth | Market Cap |
---|---|---|---|
1 Company | Estimated Growth | Market Cap | |
---|---|---|---|
Price-To-Earnings vs Industry: EMSNZ is expensive based on its Price-To-Earnings Ratio (30.8x) compared to the European Chemicals industry average (17x).
Price to Earnings Ratio vs Fair Ratio
What is EMSNZ's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 30.8x |
Fair PE Ratio | 16.4x |
Price-To-Earnings vs Fair Ratio: EMSNZ is expensive based on its Price-To-Earnings Ratio (30.8x) compared to the estimated Fair Price-To-Earnings Ratio (16.4x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | CHF 607.00 | CHF 709.57 +16.9% | 9.7% | CHF 800.00 | CHF 634.00 | n/a | 7 |
Dec ’25 | CHF 624.00 | CHF 712.86 +14.2% | 9.2% | CHF 800.00 | CHF 650.00 | n/a | 7 |
Nov ’25 | CHF 675.50 | CHF 735.71 +8.9% | 11.7% | CHF 900.00 | CHF 650.00 | n/a | 7 |
Oct ’25 | CHF 706.50 | CHF 730.63 +3.4% | 11.4% | CHF 900.00 | CHF 633.00 | n/a | 8 |
Sep ’25 | CHF 709.50 | CHF 730.63 +3.0% | 11.4% | CHF 900.00 | CHF 633.00 | n/a | 8 |
Aug ’25 | CHF 734.50 | CHF 730.63 -0.5% | 11.4% | CHF 900.00 | CHF 633.00 | n/a | 8 |
Jul ’25 | CHF 737.25 | CHF 675.00 -8.4% | 10.5% | CHF 800.00 | CHF 580.00 | n/a | 7 |
Jun ’25 | CHF 740.50 | CHF 667.14 -9.9% | 9.6% | CHF 800.00 | CHF 580.00 | n/a | 7 |
May ’25 | CHF 737.00 | CHF 664.29 -9.9% | 9.8% | CHF 800.00 | CHF 580.00 | n/a | 7 |
Apr ’25 | CHF 692.00 | CHF 664.29 -4.0% | 9.8% | CHF 800.00 | CHF 580.00 | n/a | 7 |
Mar ’25 | CHF 623.00 | CHF 655.71 +5.3% | 12.2% | CHF 800.00 | CHF 547.00 | n/a | 7 |
Feb ’25 | CHF 656.50 | CHF 657.14 +0.1% | 12.5% | CHF 800.00 | CHF 547.00 | n/a | 7 |
Jan ’25 | CHF 679.50 | CHF 657.14 -3.3% | 12.5% | CHF 800.00 | CHF 547.00 | CHF 609.50 | 7 |
Dec ’24 | CHF 619.50 | CHF 657.14 +6.1% | 12.5% | CHF 800.00 | CHF 547.00 | CHF 624.00 | 7 |
Nov ’24 | CHF 623.00 | CHF 704.57 +13.1% | 11.4% | CHF 850.00 | CHF 613.00 | CHF 675.50 | 7 |
Oct ’24 | CHF 621.00 | CHF 704.57 +13.5% | 11.4% | CHF 850.00 | CHF 613.00 | CHF 706.50 | 7 |
Sep ’24 | CHF 665.50 | CHF 700.29 +5.2% | 11.6% | CHF 850.00 | CHF 613.00 | CHF 709.50 | 7 |
Aug ’24 | CHF 726.00 | CHF 700.71 -3.5% | 11.5% | CHF 850.00 | CHF 613.00 | CHF 734.50 | 7 |
Jul ’24 | CHF 675.00 | CHF 712.86 +5.6% | 14.3% | CHF 900.00 | CHF 560.00 | CHF 737.25 | 7 |
Jun ’24 | CHF 703.00 | CHF 716.43 +1.9% | 14.5% | CHF 900.00 | CHF 575.00 | CHF 740.50 | 7 |
May ’24 | CHF 729.50 | CHF 720.71 -1.2% | 14.5% | CHF 900.00 | CHF 575.00 | CHF 737.00 | 7 |
Apr ’24 | CHF 756.00 | CHF 722.57 -4.4% | 14.4% | CHF 900.00 | CHF 575.00 | CHF 692.00 | 7 |
Mar ’24 | CHF 717.50 | CHF 702.50 -2.1% | 15.1% | CHF 900.00 | CHF 575.00 | CHF 623.00 | 6 |
Feb ’24 | CHF 682.00 | CHF 684.17 +0.3% | 16.6% | CHF 900.00 | CHF 575.00 | CHF 656.50 | 6 |
Jan ’24 | CHF 626.50 | CHF 684.17 +9.2% | 16.6% | CHF 900.00 | CHF 575.00 | CHF 679.50 | 6 |
Analyst Forecast: Target price is less than 20% higher than the current share price.
Discover undervalued companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/01/05 11:23 |
End of Day Share Price | 2025/01/03 00:00 |
Earnings | 2024/06/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
EMS-CHEMIE HOLDING AG is covered by 18 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Volker Bosse | Baader Helvea Equity Research |
Konstantin Wiechert | Baader Helvea Equity Research |
Aron Ceccarelli | Berenberg |